E. Pontara

发表

Haemostatic patterns and bleeding scores of a genetically characterised Italian family with combined haemophilia A and type 1 von Willebrand disease

F. Boscaro, V. Daidone, A. Casonato, 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease

P. Prandoni, A. Bertomoro, V. Daidone, 2016, PloS one.

Usefulness of the Total Thrombus‐Formation Analysis System (T‐TAS) in the diagnosis and characterization of von Willebrand disease

C. Romualdi, K. Hosokawa, V. Daidone, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Higher and lower active circulating VWF levels: different facets of von Willebrand disease

P. D. de Groot, M. Morpurgo, V. Daidone, 2015, British journal of haematology.

Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.

V. Daidone, A. Casonato, G. Barbon, 2015, Thrombosis research.

The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13‐resistant and reduces its collagen‐binding capacity

G. Zanotti, M. Morpurgo, V. Daidone, 2015, British journal of haematology.

C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor

M. Morpurgo, V. Daidone, A. Casonato, 2013, Thrombosis and Haemostasis.

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease

A. Bertomoro, V. Daidone, A. Casonato, 2011, Haematologica.

Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series.

A. Bertomoro, R. Padrini, V. Daidone, 2010, Translational research : the journal of laboratory and clinical medicine.

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

Alessandra Casonato, A. Bertomoro, R. Padrini, 2010, Haematologica.

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.

A. Bertomoro, R. Padrini, V. Daidone, 2008, Blood.

A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function.

S. Marcato, A. Casonato, E. Pontara, 2004, The Journal of laboratory and clinical medicine.

An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant.

A. Bertomoro, A. Girolami, A. Casonato, 2003, Blood.

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co‐factor activity?

A. Bertomoro, A. Girolami, A. Casonato, 2001, British journal of haematology.

Insight into the hypercoagulable state of high‐risk thrombotic APS patients: Contribution of aβ2GPI and aPS/PT antibodies

V. Pengo, E. Bison, G. Denas, 2020, Journal of thrombosis and haemostasis : JTH.

Preliminary hemocompatibility assessment of an innovative material for blood contacting surfaces

G. Gerosa, V. Pengo, E. Pontara, 2021, Journal of Materials Science: Materials in Medicine.

Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome.

C. Romualdi, C. Scaroni, N. Albiger, 2010, Thrombosis research.

Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease.

A. Bertomoro, A. Girolami, P. Zerbinati, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease.

A. Girolami, R. Padrini, A. Casonato, 2002, Blood.

Post-DDAVP Thrombocytopenia in Type 2B von Willebrand Disease Is not Associated with Platelet Consumption: Failure to Demonstrate Glycocalicin Increase or Platelet Activation

A. Girolami, A. Steffan, A. Zucchetto, 1999, Thrombosis and Haemostasis.

Antibody profiles comprising anti phosphatidylserine/prothrombin differently affect thrombin generation and protein C resistance in antiphospholipid antibody carriers.

V. Pengo, E. Bison, G. Denas, 2020, Clinica chimica acta; international journal of clinical chemistry.

Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies

S. Iliceto, S. Rizzo, M. De Gaspari, 2022, European journal of heart failure.

Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates

S. Iliceto, C. Campochiaro, G. de Luca, 2021, Diagnostics.

Serum Anti-Heart and Anti-Intercalated Disk Autoantibodies: Novel Autoimmune Markers in Cardiac Sarcoidosis

S. Iliceto, M. Plebani, A. Caforio, 2021, Journal of clinical medicine.

EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA.

A. Bertomoro, A. Girolami, A. Casonato, 1994, Journal of clinical pathology.

Coagulation Activation in Children with Sickle Cell Disease Is Associated with Cerebral Small Vessel Vasculopathy

G. Basso, A. Bertomoro, R. Manara, 2013, PloS one.

A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis

A. Bertomoro, V. Daidone, A. Casonato, 2007, Thrombosis and Haemostasis.

Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease

A. Bertomoro, L. Bartoloni, A. Casonato, 2006, Thrombosis and Haemostasis.

The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications.

A. Girolami, P. Zerbinati, A. Zucchetto, 1998, American journal of clinical pathology.

Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers.

A. Bertomoro, A. Girolami, P. Zerbinati, 1997, The Journal of laboratory and clinical medicine.

Impaired release of tissue plasminogen activator (t‐PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content

A. Girolami, G. Patrassi, A. Zucchetto, 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

New Insight into the Hypercoagulability of Cushing’s Syndrome

G. Occhi, M. Boscaro, C. Scaroni, 2011, Neuroendocrinology.

Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome.

M. Boscaro, N. Sonino, A. Girolami, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Abnormally large von Willebrand factor multimers in Henoch‐Schönlein purpura

A. Bertomoro, A. Girolami, E. Ossi, 1996, American journal of hematology.

Diagnosis and Follow-up of Thrombotic Thrombocytopenic Purpura by Means of von Willebrand Factor Collagen Binding Assay

F. Fabris, A. Girolami, A. Casonato, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor.

A. Bertomoro, A. Girolami, A. Casonato, 2003, Haematologica.

Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization.

A. Bertomoro, A. Girolami, A. Casonato, 2001, The Journal of laboratory and clinical medicine.

Identifying type Vicenza von Willebrand disease.

A. Rosato, A. Bertomoro, R. Padrini, 2006, The Journal of laboratory and clinical medicine.

Inhibitory Effect of Prostacyclin and Nitroprusside on Type IIB von Willebrand Factor-promoted Platelet Activation

R. Deana, A. Girolami, A. Donella‐Deana, 1996, Thrombosis and Haemostasis.

Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease

R. Padrini, V. Daidone, A. Casonato, 2008, British journal of haematology.

Plasma and Platelet von Willebrand Factor Abnormalities in Patients With Uremia: Lack of Correlation With Uremic Bleeding

A. Girolami, A. Steffan, A. Casonato, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Tetra positive thrombotic antiphospholipid syndrome: Major contribution of anti‐phosphatidyl‐serine/prothrombin antibodies to lupus anticoagulant activity

V. Pengo, E. Bison, G. Denas, 2020, Journal of thrombosis and haemostasis : JTH.

Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease

A. Girolami, P. Gresele, E. Zanon, 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome

A. Bertomoro, A. Doria, A. Girolami, 2002, British journal of haematology.

Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor.

A. Girolami, D. Gemmati, A. Casonato, 2001, Haematologica.

Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.

M. Boscaro, A. Girolami, A. Casonato, 1993, Haematologia.

Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome

S. Altinier, V. Pengo, L. Zardo, 2020, TH Open.

A common ancestor more than 10,000 years old for patients with R854Q-related type 2N von Willebrand's disease in Italy

L. Marullo, G. Bertorelle, V. Daidone, 2013, Haematologica.

Identifying Carriers of Type 2N von Willebrand Disease

A. Bertomoro, P. Perutelli, A. Casonato, 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis.

A. Girolami, S. Gavasso, L. Spiezia, 2003, Thrombosis and haemostasis.

Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors

A. Bertomoro, A. Girolami, M. Zaninotto, 1995, Annals of Hematology.

Platelet Aggregation Induced by Plasma from Type IIB von Willebrand’s Disease Patients Is Associated with an Increase in Cytosolic Ca2+ Concentration

R. Deana, A. Girolami, A. Casonato, 1993, Thrombosis and Haemostasis.

TYPE I PADUA: A NEW VARIANT OF VON WILLEBRAND'S DISEASE

A. Bertomoro, A. Girolami, A. Casonato, 1992, British Journal of Haematology.

Type IIB von Willebrand factor induces phospholipase A2 activation and cytosolic Ca2+ increase in platelets.

R. Deana, L. Dalla Via, A. Girolami, 1995, Biochemical and biophysical research communications.

Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor.

A. Girolami, G. Patrassi, A. Casonato, 1992, Thrombosis research.